SHAP analysis further focused on 3 key genes, IGFBP1, ENO3 and SOSC2. Importantly, we also identified Daidzein, a potential natural drug against MASLD. The gene discussed is IGFBP1; the disease is metabolic dysfunction-associated steatotic liver disease.